Palivizumab
MCE 国际站：Palivizumab
CAS：188039-54-5
品牌：MedChemExpress (MCE)
存储条件：Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性：Palivizumab (MEDI 493) 是一种人源化呼吸道合胞病毒单克隆抗体，可减少呼吸道合胞病毒感染 (RSV)。
热销产品：Mifepristone | Elacestrant | Oridonin | OVA Peptide (323-339) | TPPU | KL-11743 | Taurocholic acid | Mifamurtide | Sunitinib | Cordycepin
研究领域：Anti-infection
作用靶点：RSV
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献：
[1]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.